中文 | English
Return
Total: 410 , 1/41
Show Home Prev Next End page: GO
Author:(Xiao Fei LU)

1.Genetic analysis and reproductive intervention for 46 Chinese pedigrees affected with Hereditary multiple exostoses.

Lilan SU ; Xiao HU ; Jing DAI ; Zhengxing WAN ; Duo YI ; Shuangfei LI ; Liang HU ; Yueqiu TAN ; Fei GONG ; Ge LIN ; Guangxiu LU ; Qianjun ZHANG ; Juan DU ; Wenbin HE

Chinese Journal of Medical Genetics 2026;43(4):253-258

2.Gender-specific patterns of external occipital protuberance hyperplasia: associations with nuchal ligament ossification and cervical sagittal imbalance in myelopathy patients

Zhaoyang GONG ; Hanqiu SUN ; Dachuan LI ; Xiao LU ; Siyang LIU ; Ximeng WANG ; Xinlei XIA ; Feizhou LYU ; Jianyuan JIANG ; Fei ZOU ; Hongli WANG ; Xiaosheng MA

Asian Spine Journal 2026;20(1):10-19

3.Comparison on odor components before and after processing of Cervi Cornu Pantotrichum based on electronic nose, HS-GC-MS, and odor activity value.

Xiao-Yu YAO ; Ke SHEN ; Di WU ; Xiao-Fei SUN ; Chun-Qin MAO ; Li FU ; Xiao-Yan WANG ; Hui XIE ; Tu-Lin LU

China Journal of Chinese Materia Medica 2025;50(2):421-431

4.Mineralogical studies on iron-containing mineral medicines, Haematitum and Limonitum.

Min LU ; Xiao-Fei WANG ; Cheng-Cheng WANG ; Jing-Xu CHEN ; Hang-Jie ZHU ; Juan LI ; Yan CAO

China Journal of Chinese Materia Medica 2025;50(5):1179-1186

5.Jianpi Qinghua Formula improves metabolic-associated fatty liver disease by modulating PGC1α/PPARα/CPT1A pathway.

Yan-Yan XIAO ; Xu HAN ; Qing-Guang CHEN ; Jun-Fei XU ; Chi CHEN ; Fan GONG ; Hao LU

China Journal of Chinese Materia Medica 2025;50(9):2505-2514

6.Perturbation response scanning of drug-target networks: Drug repurposing for multiple sclerosis.

Yitan LU ; Ziyun ZHOU ; Qi LI ; Bin YANG ; Xing XU ; Yu ZHU ; Mengjun XIE ; Yuwan QI ; Fei XIAO ; Wenying YAN ; Zhongjie LIANG ; Qifei CONG ; Guang HU

Journal of Pharmaceutical Analysis 2025;15(6):101295-101295

7.International clinical practice guideline on the use of traditional Chinese medicine for functional dyspepsia (2025).

Sheng-Sheng ZHANG ; Lu-Qing ZHAO ; Xiao-Hua HOU ; Zhao-Xiang BIAN ; Jian-Hua ZHENG ; Hai-He TIAN ; Guan-Hu YANG ; Won-Sook HONG ; Yu-Ying HE ; Li LIU ; Hong SHEN ; Yan-Ping LI ; Sheng XIE ; Jin SHU ; Bin-Fang ZENG ; Jun-Xiang LI ; Zhen LIU ; Zheng-Hua XIAO ; Jing-Dong XIAO ; Pei-Yong ZHENG ; Shao-Gang HUANG ; Sheng-Liang CHEN ; Gui-Jun FEI

Journal of Integrative Medicine 2025;23(5):502-518

8.Identifying High-Risk Areas for Type 2 Diabetes Mellitus Mortality in Guangdong, China: Spatiotemporal Clustering and Socioenvironmental Determinants.

Hai Ming LUO ; Wen Biao HU ; Yan Jun XU ; Xue Yan ZHENG ; Qun HE ; Lu LYU ; Rui Lin MENG ; Xiao Jun XU ; Fei ZOU

Biomedical and Environmental Sciences 2025;38(5):585-597

9.Correlation of characteristics of symptomatic middle cerebral artery plaques with risk of stroke recurrence:Study based on high-resolution vessel wall imaging

Xing-xing ZENG ; Li-rong WANG ; Zhi-guo GAO ; Jin-fei LU ; Xiao-li JIANG ; Xiao-yi LI

Chinese Medical Equipment Journal 2025;46(2):63-67

10.Research advances of CXCL12/CXCR4 in the rheumatoid arthritis pathogenesis

Hong-mei YANG ; Hao-lin LI ; Juan-juan YANG ; Xiao-jun SU ; Hai-tao LEI ; Dong-sheng LU ; Li-li KAN ; Peng-fei TAO ; Hai-dong WANG

Chinese Pharmacological Bulletin 2025;41(2):230-234

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 410 , 1/41 Show Home Prev Next End page: GO